Skip to main content

b2venture — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

132
Companies
$1.7B
Total invested
$13.0M
Avg. check
43
Industries
Software 6Artificial Intelligence (AI) 5Health Care 5Biotechnology 5Medical 3Pharmaceutical 3+37 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 132
1Komma5°
October 2026

1Komma5° is a home electrification and climatetech company that provides intelligent energy solutions and promotes a CO₂-neutral lifestyle.

Charging Infrastructure · Hamburg$78.5M Private Equity
Procuros
October 2026

Procuros is a fintech company that offers a platform for turning manual B2B transactions into transparent and automated flows.

Software · Hamburg$22.3M Series A
Vamstar
October 2026

Vamstar is the agentic AI platform for commercial teams in Pharma and MedTech: tenders, pricing and market access in 100+ countries.

Artificial Intelligence (AI) · London$1.2M Grant
Flyboard
July 2026

Flyboard specializing in AI-powered voice agents for the mid-market

Barcelona$2.2M Pre-Seed
Everlab
June 2026

Everlab is a health-tech company building the ecosystem for preventive health

Health Care · Sydney$46.0M Series A
PAVE Space
March 2026

PAVE Space develops in-space transportation and satellite servicing technologies that enable movement and management of payloads.

Information Technology · Crissier$40.0M Seed
Sitegeist
February 2026

Sitegeist Robotics is a Munich-based startup that develops modular, AI-powered robots for the construction industry.

Artificial Intelligence (AI) · Munich$4.7M Pre-Seed
Demoboost
February 2026

Demoboost experience that sells. Easily create, share, and track your product demos.

Marketing · Warsaw$3.3M Seed
SamanTree Medical
January 2026

SamanTree Medical is an innovative Swiss company, developing a medical device to acquire tissue images during surgical cancer intervention.

Biotechnology · Lausanne$23.7M Debt Financing
Aeovian Pharmaceuticals
December 2025

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Biopharma · San Francisco$55.0M Series B
Amplifold
December 2025

Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology.

Biopharma · Munich$5.8M Seed
Hive Robotics
September 2025

Hive Robotics is developing scalable, cutting-edge technology designed to safely and securely command, control, and connect etc.

Robotics · Munich$2.3M Pre-Seed
Calvin Risk
September 2025

Calvin Risk develops comprehensive and quantitative solutions to assess and manage the risks of AI algorithms in commercial use.

Artificial Intelligence (AI) · KlotenGrant
Nautica Technologies
July 2025

Nautica Technologies is developing intelligent robotic technologies for autonomous ship hull cleaning and inspection.

Robotics · Zürich$4.0M Seed
EFFECT Photonics
June 2025

EFFECT Photonics is a highly vertically integrated, independent leader in integrated optics.

Mobile · Eindhoven$24.0M Series D
Kiin Bio
June 2025

Kiin Bio operates as an AI-native platform that unifies drug discovery tools.

Artificial Intelligence (AI) · London$2.2M Pre-Seed
Edurino
May 2025

Edurino is an e-learning platform that introduces digital learning responsibly and playfully for children aged 4-8+.

Children · MunichSeries B
VESTIGAS
April 2025

VESTIGAS is the new standard for Purchase-to-Pay Interactions in Construction.

Construction · Eggenfelden$8.8M Seed
Miss Moneypenny Technologies
April 2025

Miss Moneypenny Technologies offers a journey-builder for wallet passes in native digital wallet apps (Apple Wallet and Google Pay)

Information Services · Berlin$8.0M Seed
Vantis
March 2025

Vantis is a digital solution for chronic cardiovascular diseases that requires personalized ongoing treatment for decades.

Health Care · Munich$10.9M Series A
assemblean
February 2025

assemblean goal is to construct the digital manufacturing infrastructure of the future.

PaaS · Paderborn$1.9M Seed
NOAT
January 2025

Nicotine without the noise.

Consumer · New York$7.0M Seed
Liom
December 2024

Liom develops the ultimate wearable to monitor needle-free biomarkers, beginning with glucose.

Artificial Intelligence (AI) · Pfäffikon$25.0M Series A
Predium
November 2024

The Real Estate Intelligence Platform for sustainable capital decisions

Information Services · Munich$13.7M Series A

Where b2venture invests

Software6
Artificial Intelligence (AI)5
Health Care5
Biotechnology5
Medical3
Pharmaceutical3

About b2venture's portfolio

How many companies has b2venture invested in?▸

b2venture has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does b2venture invest in?▸

b2venture's top investment sectors include Software, Artificial Intelligence (AI), Health Care, Biotechnology, Medical. The firm invests across 43 different industry categories.

What is b2venture's largest investment?▸

Among tracked funding rounds, 1Komma5° received $78.5M in a Private Equity round. b2venture's total known invested capital is $1.7B.

What is the average investment size for b2venture?▸

b2venture's average investment size is $13.0M across its portfolio of 132 companies.

What are b2venture's most recent investments?▸

Recent b2venture portfolio additions include 1Komma5°, Procuros, Vamstar, Flyboard, Everlab. These companies were founded in 2020 or later.

Reach the founders behind these 132 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →